Safety, tolerability, and efficacy of diroximel fumarate in a cohort of Black patients with multiple sclerosis from the phase 3 EVOLVE-MS-1 study

Update your browser to view ScienceDirect.

Request details:

Request ID: 8d127fc66b811686-LAX
IP: 116.62.10.13
UTC time: 2024-10-11T23:06:10+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4